Chronic antidepressants induce redistribution and differential activation of αcaM kinase II between presynaptic compartments

Neuropsychopharmacology

Volumn 32, Issue 12, 2007, Pages 2511-2519

  Barbiero, Valentina S ^a,b   Giambelli, Roberto ^a   Musazzi, Laura ^a   Tiraboschi, Ettore ^a   Tardito, Daniela ^a   Perez, Jorge ^b   Drago, Filippo ^c   Racagni, Giorgio ^a,b   Popoli, Maurizio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antidepressant; CaM kinase II; Glutamate; Neurotransmitter release; Synaptic plasticity

Indexed keywords

DESIPRAMINE; FLUOXETINE; GLUTAMIC ACID; PROTEIN KINASE (CALCIUM,CALMODULIN) II; REBOXETINE; SYNAPSIN I; THREONINE; TISSUE EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COMPARTMENTALIZATION; CONTROLLED STUDY; DRUG EFFECT; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SYNAPSE VESICLE; SYNAPTIC MEMBRANE; SYNAPTOSOME;

ANIMALS; ANTIDEPRESSIVE AGENTS; CADHERINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; SUBCELLULAR FRACTIONS; SYNAPTOPHYSIN; SYNAPTOSOMES;

EID: 36249024272     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301378     Document Type: Article

References (46)

1. Bagley J, Moghaddam B (1997). Temporal dynamics of glutamate efflux in the prefrontal cortex and in the hippocampus following repeated stress: effects of pretreatment with saline or diazepam. Neuroscience 77: 65-73.
2. Bagni C, Mannucci L, Dotti CG, Amaldi F (2000). Chemical stimulation of synaptosomes modulates alpha -Ca2+/calmodulin-dependent protein kinase II mRNA association to polysomes. J Neurosci 20: RC76.
3. Bayer KU, De Koninck P, Leonard AS, Hell JW, Schulman H (2001). Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 411: 801-805.
4. Bayer KU, Harbers K, Schulman H (1998). alphaKAP is an anchoring protein for a novel CaM kinase II isoform in skeletal muscle. EMBO J 17: 5598-5605.
5. Benfenati F, Onofri F, Czernik AJ, Valtorta F (1996). Biochemical and functional characterization of the synaptic vesicle-associated form of CA2+/calmodulin-dependent protein kinase II. Brain Res Mol Brain Res 40: 297-309.
6. Benfenati F, Valtorta F, Rubenstein JL, Gorelick FS, Greengard P, Czernik AJ (1992). Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature 359: 417-420.
7. Bonanno G, Giambelli R, Raiteri L, Tiraboschi E, Zappettini S, Musazzi L et al (2005). Chronic antidepressants reduce depolarization-evoked glutamate release and protein interactions favoring formation of SNARE complex in hippocampus. J Neurosci 25: 3270-3279.
8. Celano E, Tiraboschi E, Consogno E, D'Urso G, Mbakop MP, Gennarelli M et al (2003). Selective regulation of presynaptic calcium/calmodulin- dependent protein kinase II by psychotropic drugs. Biol Psychiatry 53: 442-449.
9. Coyle JT, Duman RS (2003). Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38: 157-160.
10. Dunkley PR, Jarvie PE, Heath JW, Kidd GJ, Rostas JA (1986). A rapid method for isolation of synaptosomes on Percoll gradients. Brain Res 372: 115-129.
11. Fink CC, Bayer KU, Myers JW, Ferrell Jr JE, Schulman H, Meyer T (2003). Selective regulation of neurite extension and synapse formation by the beta but not the alpha isoform of CaMKII. Neuron 39: 283-297.
12. Glowinski J, Iversen LL (1966). Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem 13: 655-669.
13. Griffith LC, Lu CS, Sun XX (2003). CaMKII, an enzyme on the move: regulation of temporospatial localization. Mol Interv 3: 386-403.
14. Hinds HL, Goussakov I, Nakazawa K, Tonegawa S, Bolshakov VY (2003). Essential function of alpha-calcium/calmodulin-dependent protein kinase II in neurotransmitter release at a glutamatergic central synapse. Proc Natl Acad Sci USA 100: 4275-4280.
15. Hudmon A, Schulman H (2002). Neuronal CA2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71: 473-510.
16. Huttner WB, Schiebler W, Greengard P, De Camilli P (1983). Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol 96: 1374-1388.
17. Jovanovic JN, Czernik AJ, Fienberg AA, Greengard P, Sihra TS (2000). Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 3: 323-329.
18. Lisman J, Schulman H, Cline H (2002). The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci 3: 175-190.
19. Magarinos AM, Verdugo JM, McEwen BS (1997). Chronic stress alters synaptic terminal structure in hippocampus. Proc Natl Acad Sci USA 94: 14002-14008.
20. Manji HK, Drevets WC, Charney DS (2001). The cellular neurobiology of depression. Nat Med 7: 541-547.
21. McEwen BS (1999). Stress and hippocampal plasticity. Annu Rev Neurosci 22: 105-122.
22. Mehta PP, Battenberg E, Wilson MC (1996). SNAP-25 and synaptotagmin involvement in the final Ca(2+)-dependent triggering of neurotransmitter exocytosis. Proc Natl Acad Sci USA 93: 10471-10476.
23. Mullen RJ, Buck CR, Smith AM (1992). NeuN, a neuronal specific nuclear protein in vertebrates. Development 116: 201-211.
24. Ouyang Y, Rosenstein A, Kreiman G, Schuman EM, Kennedy MB (1999). Tetanic stimulation leads to increased accumulation of Ca(2+)/calmodulin-dependent protein kinase II via dendritic protein synthesis in hippocampal neurons. J Neurosci 19: 7823-7833.
25. Pilc A, Branski P, Palucha A, Aronowski J (1999). The effect of prolonged imipramine and electroconvulsive shock treatment on calcium/calmodulin- dependent protein kinase II in the hippocampus of rat brain. Neuropharmacology 38: 597-603.
26. Popoli M, Gennarelli M, Racagni G (2002). Modulation of synaptic plasticity by stress and antidepressants. Bipolar Disord 4: 166-182.
27. Popoli M, Paternò R (1991). Properties of a synaptic vesicle protein binding plasma membranes. Neuroreport 2: 93-95.
28. Popoli M, Vocaturo C, Perez J, Smeraldi E, Racagni G (1995). Presynaptic Ca2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. Mol Pharmacol 48: 623-629.
29. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E et al (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for anti-depressant-induced behavioral effects. J Neurosci 23: 349-357.
30. Sapolsky RM (2000). The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 48: 755-765.
31. Schikorski T, Stevens CF (2001). Morphological correlates of functionally defined synaptic vesicle populations. Nat Neurosci 4: 391-395.
32. Shakesby AC, Anwyl R, Rowan MJ (2002). Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J Neurosci 22: 3638-3644.
33. Shen K, Teruel MN, Connor JH, Shenolikar S, Meyer T (2000). Molecular memory by reversible translocation of calcium/calmodulin-dependent protein kinase II. Nat Neurosci 3: 881-886.
34. Shen K, Teruel MN, Subramanian K, Meyer T (1998). CaMKIIbeta functions as an F-actin targeting module that localizes CaMKIIalpha/beta heterooligomers to dendritic spines. Neuron 21: 593-606.
35. Spedding M, Jay T, Costa e Silva J, Perret L (2005). A pathophysiological paradigm for the therapy of psychiatric disease. Nat Rev Drug Discov 4: 467-476.
36. Srinivasan M, Edman CF, Schulman H (1994). Alternative splicing introduces a nuclear localization signal that targets multifunctional CaM kinase to the nucleus. J Cell Biol 126: 839-852.
37. Strack S, Robison AJ, Bass MA, Colbran RJ (2000). Association of calcium/calmodulin-dependent kinase II with developmentally regulated splice variants of the postsynaptic density protein densin-180. J Biol Chem 275: 25061-25064.
38. Sun XX, Hodge JJ, Zhou Y, Nguyen M, Griffith LC (2004). The eag potassium channel binds and locally activates calcium/calmodulin-dependent protein kinase II. J Biol Chem 279: 10206-10214.
39. Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M (2006). Signaling pathways regulating gene expression, neuroplasticity and neurothrophic mechanisms in the action of antidepressants. A critical overview. Pharmacol Rev 58: 115-134.
40. Thiagarajan TC, Piedras-Renteria ES, Tsien RW (2002). Alpha- and betaCaMKII. Inverse regulation by neuronal activity and opposing effects on synaptic strength. Neuron 36: 1103-1114.
41. Tiraboschi E, Giambelli R, D'Urso G, Galietta A, Barbon A, de Bartolomeis A et al (2004a). Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation. Neuroreport 15: 2393-2396.
42. Tiraboschi E, Tardito D, Kasahara J, Moraschi S, Pruneri P, Gennarelli M et al (2004b). Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades. Neuropsychopharmacology 29: 1831-1840.
43. Verona M, Zanotti S, Schafer T, Racagni G, Popoli M (2000). Changes of synaptotagmin interaction with t-SNARE proteins in vitro after calcium/calmodulin-dependent phosphorylation. J Neurochem 74: 209-221.
44. Wong ML, Licinio J (2004). From monoamines to genomic targets: a paradigm shift for drug discovery in depression. Nat Rev Drug Discov 3: 136-151.
45. Zarate Jr CA, Du J, Quiroz J, Gray NA, Denicoff KD, Singh J et al (2003). Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system. Ann NY Acad Sci 1003: 273-291.
46. Zarate CA, Quiroz J, Payne J, Manji HK (2002). Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders. Psychopharmacol Bull 36: 35-83.